Symbol="ARWR"
AssetType="Common Stock"
Name="Arrowhead Pharmaceuticals Inc"
Description="Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California."
CIK="879407"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="3383385000"
EBITDA="-140096000"
PERatio="None"
PEGRatio="-1.32"
BookValue="4.181"
DividendPerShare="0"
DividendYield="0"
EPS="-1.44"
RevenuePerShareTTM="2.571"
ProfitMargin="-0.551"
OperatingMarginTTM="-0.552"
ReturnOnAssetsTTM="-0.118"
ReturnOnEquityTTM="-0.332"
RevenueTTM="272800000"
GrossProfitTTM="243231000"
DilutedEPSTTM="-1.44"
QuarterlyEarningsGrowthYOY="0.098"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="62.15"
TrailingPE="-"
ForwardPE="111.11"
PriceToSalesRatioTTM="14.71"
PriceToBookRatio="8.04"
EVToRevenue="11.97"
EVToEBITDA="-17.32"
Beta="0.957"
num_52WeekHigh="48.48"
num_52WeekLow="23.09"
num_50DayMovingAverage="34.9"
num_200DayMovingAverage="33.21"
SharesOutstanding="106900000"
DividendDate="None"
ExDividendDate="None"
symbol="ARWR"
open="32.31"
high="32.74"
low="31.57"
price="31.65"
volume="663503.00"
latest_trading_day="2023-08-04"
previous_close="32.32"
change="-0.67"
change_percent="-2.0730%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="1010332"
Change_recent_avg="-0.08"
Delta_recent_avg="1.31"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="1121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_negative_thumbnail_id_2="166"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0010.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="977"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_positive_thumbnail_id_2="988"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
